Clinical Trial Update: Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from University of Zurich evaluating ex vivo drug response to guide next-generation care of brain metastases; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: University of Zurich | Conditions: Brain Metastases, Brain Metastases, Adult | Phase 2 | Status: RECRUITING